DEP Updates from AGM Presentation November 2020.
- DEP docetaxel - Was 37 now 40 (+3) - Not sure what trial figures are said to be for phase 2.
- DEP cabazitaxel - Was 17 with phase 2 first stage trail participant aim of 30 - Now 35 (+18) - appears over and above aim
- DEP Irinotecan - Phase 2 was 27 now 40 +13 - Not sure on population target
Appears to me that recruitment has gone well and at least one trial is fully recruited, anyone else have views on enrollment numbers please?
- Forums
- ASX - By Stock
- DEP Enrollment Update
DEP Updates from AGM Presentation November 2020.DEP docetaxel -...
-
- There are more pages in this discussion • 45 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
|
|||||
Last
9.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $38.81M |
Open | High | Low | Value | Volume |
9.3¢ | 9.3¢ | 9.3¢ | $62.64K | 673.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 445366 | 9.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.5¢ | 2000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 580558 | 0.093 |
1 | 10331 | 0.090 |
2 | 41247 | 0.089 |
2 | 116000 | 0.088 |
1 | 73255 | 0.087 |
Price($) | Vol. | No. |
---|---|---|
0.095 | 2000 | 1 |
0.096 | 100000 | 1 |
0.097 | 50309 | 2 |
0.098 | 200000 | 1 |
0.100 | 116000 | 4 |
Last trade - 10.15am 12/09/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |